Ethyl 6-methyl-2-(4-(piperidin-1-ylsulfonyl)benzamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxylate hydrochloride

Catalog No. :
ACARWJ955
CAS No. :
1330343-84-4
Molecular Formula :
C23H30ClN3O5S2
Molecular Weight :
528.10

IUPAC Name:ethyl 6-methyl-2-(4-(piperidin-1-ylsulfonyl)benzamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxylate hydrochloride

Ethyl 6-methyl-2-(4-(piperidin-1-ylsulfonyl)benzamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxylate hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 6-methyl-2-(4-(piperidin-1-ylsulfonyl)benzamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxylate hydrochloride
IUPAC Nameethyl 6-methyl-2-(4-(piperidin-1-ylsulfonyl)benzamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxylate hydrochloride
Molecular FormulaC23H30ClN3O5S2
Molecular Weight528.10
SMILESO=C(C1=C(NC(C2=CC=C(S(=O)(N3CCCCC3)=O)C=C2)=O)SC4=C1CCN(C)C4)OCC.[H]Cl
InChI KeyMEDXSLFKRBXEDA-UHFFFAOYSA-N
Synonymethyl 6-methyl-2-(4-(piperidin-1-ylsulfonyl)benzamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxylate hydrochloride
CAS No.1330343-84-4

Synthetic Route by SureRoute

1. ACARWJ955 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFCRD180 route compound structure diagram
    ACFCRD18024237-39-6 In Stock
  2. Plus
  3. ACYINO365 route compound structure diagram
    ACYINO36510252-83-2 In Stock
  4. Then
  5. ACARWJ955 route product structure diagram
    ACARWJ9551330343-84-4
Inquiry

2. ACARWJ955 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACARWJ955 route product structure diagram
    ACARWJ9551330343-84-4
Inquiry

Comments (0)